Continuous Glucose Monitor Data
Buy and sell continuous glucose monitor data data. 24/7 blood glucose readings showing food, exercise, and medication responses. Diabetes management AI personalizes treatment from CGM data.
No listings currently in the marketplace for Continuous Glucose Monitor Data.
Find Me This Data →Overview
What Is Continuous Glucose Monitor Data?
Continuous glucose monitors (CGMs) are wearable biosensors that automatically measure blood glucose levels at regular intervals—ranging from every 1 to 15 minutes—from interstitial fluid. This minimally invasive technology uses a small sterile filament placed under the skin and transmits readings to a mobile display via smartphone app, wearable device, or cycling computer. CGMs enable real-time visibility of glucose levels and allow users to tag events such as meals, exercise, and medication to understand how daily activities affect blood sugar. Beyond diabetes management, CGM data is increasingly adopted by individuals without diabetes seeking to optimize health and wellness. The data generated provides continuous streams that help identify glycemic variability rapidly and inform timely corrective actions, making it essential for personalized diabetes management and AI-driven therapeutic decisions.
Market Data
USD 8.98 billion
Global CGM Market Value (2025)
Source: IntechOpen
USD 17.12 billion
Global CGM Market Projection (2030)
Source: IntechOpen
13.76%
Global CGM Market CAGR
Source: IntechOpen
USD 3.09 billion
Europe CGM Market Value (2025)
Source: Market Data Forecast
USD 10.97 billion
Europe CGM Market Projection (2034)
Source: Market Data Forecast
Who Uses This Data
What AI models do with it.do with it.
Type 1 Diabetes Management
Patients with Type 1 diabetes use CGM data to titrate insulin doses and maintain stable blood sugar levels, with real-time glucose data enabling earlier detection of glycemic fluctuations and more informed therapeutic decisions.
Type 2 Diabetes Monitoring
Individuals with Type 2 diabetes leverage CGM readings to understand medication responses, optimize carbohydrate intake timing, and assess how food and exercise impact glucose control.
Non-Diabetic Health Optimization
People without diabetes increasingly use CGM data to optimize personal health and wellness, identifying how dietary choices and exercise patterns affect their glucose levels and overall metabolic function.
Athletic Performance & Sports Nutrition
Athletes use CGM data to understand optimal carbohydrate feeding timing and dosage during exercise, matching contemporary sports nutrition guidelines and enhancing performance while avoiding hypoglycemia.
What Can You Earn?
What it's worth.worth.
Data Access & Integration
Varies
Organizations may negotiate contracts with CGM vendors for data access; pricing depends on data volume, integration scope, and existing contractual relationships with vendors.
What Buyers Expect
What makes it valuable.valuable.
Real-Time Accuracy
CGM data must provide accurate glucose readings at consistent intervals (1 to 15 minutes) with Mean Absolute Relative Difference (MARD) standards in the 7-9% range to support clinical decision-making.
Standardized Metrics & Formats
Data should conform to the 2019 International Consensus standards for 10 discrete CGM metrics and Ambulatory Glucose Profile (AGP) reporting, enabling interoperability across clinical systems.
Event Integration Capability
High-quality datasets include event tagging for meals, exercise, medication, and other contextual factors; integration with food trackers and external services enhances analytical value.
Extended Wear Time & Sensor Technology
Buyers expect devices with extended wear times and higher accuracy rates, reflecting advances in sensor technology and manufacturing refinement across competing platforms.
Companies Active Here
Who's buying.buying.
Market leader in CGM device manufacturing and distribution; develops integrated monitoring solutions with focus on product innovation and strategic partnerships.
Prominent CGM manufacturer; pioneered over-the-counter continuous glucose monitors (Stelo) cleared by FDA for non-prescription use in 2024.
Major competitor investing in advanced sensor technologies and automated insulin delivery systems integrated with CGM data.
Key market player focused on CGM innovation and expanding geographic presence across Europe and global markets.
Hospitals, clinics, and diabetes research centers integrate multi-vendor CGM data platforms to standardize glucose metrics for patient care and clinical research.
FAQ
Common questions.questions.
What intervals do CGM devices measure glucose at?
CGM devices automatically measure glucose at regular intervals ranging from every 1 minute to every 15 minutes from interstitial fluid, with readings displayed in real-time on mobile apps, wrist-worn wearables, or cycling computers.
Who can use continuous glucose monitors?
While CGMs were traditionally prescribed to diabetics for medication titration, they are increasingly used by people without diabetes to optimize health and wellness. The FDA cleared over-the-counter CGM options in 2024, expanding accessibility beyond prescription-only models.
What is the typical cost of CGM monitoring?
Individual CGM devices are reasonably cost-effective at approximately USD 7 per day. Full CGM systems may cost up to USD 200 per month depending on components included; high device costs and limited insurance coverage remain barriers to adoption.
How is CGM data used for diabetes management?
CGM data enables real-time glucose visibility, allowing users to identify glycemic variability rapidly and initiate timely corrective actions. The continuous data streams help with insulin titration, understanding food and exercise responses, and making informed therapeutic decisions compared to traditional intermittent capillary glucose measurements.
Sell yourcontinuous glucose monitordata.
If your company generates continuous glucose monitor data, AI companies are actively looking for it. We handle pricing, compliance, and buyer matching.
Request Valuation